-
1
-
-
65649151375
-
Effects of nanomaterial physicochemical properties on in vivo toxicity
-
10.1016/j.addr.2009.03.010
-
K.L. Aillon, Y. Xie, N. El-Gendy, C.J. Berkland, and M.L. Forrest Effects of nanomaterial physicochemical properties on in vivo toxicity Adv. Drug Deliv. Rev. 61 2009 457 466 10.1016/j.addr.2009.03.010
-
(2009)
Adv. Drug Deliv. Rev.
, vol.61
, pp. 457-466
-
-
Aillon, K.L.1
Xie, Y.2
El-Gendy, N.3
Berkland, C.J.4
Forrest, M.L.5
-
2
-
-
84884126183
-
Lipid nanoparticles for brain targeting. III. Long-term stability and in vivo toxicity
-
10.1016/j.ijpharm.2013.06.037
-
P. Blasi, A. Schoubben, G. Traina, G. Manfroni, L. Barberini, P.F. Alberti, C. Cirotto, and M. Ricci Lipid nanoparticles for brain targeting. III. Long-term stability and in vivo toxicity Int. J. Pharm. 454 2013 316 323 10.1016/j.ijpharm.2013.06.037
-
(2013)
Int. J. Pharm.
, vol.454
, pp. 316-323
-
-
Blasi, P.1
Schoubben, A.2
Traina, G.3
Manfroni, G.4
Barberini, L.5
Alberti, P.F.6
Cirotto, C.7
Ricci, M.8
-
3
-
-
72049114741
-
Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems
-
10.1016/j.jchromb.2009.10.020
-
A. Estella-Hermoso de Mendoza, M.A. Campanero, F. Mollinedo, and M.J. Blanco-Prieto Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems J. Chromatogr. B 877 2009 4035 4041 10.1016/j.jchromb.2009.10.020
-
(2009)
J. Chromatogr. B
, vol.877
, pp. 4035-4041
-
-
Estella-Hermoso De Mendoza, A.1
Campanero, M.A.2
Mollinedo, F.3
Blanco-Prieto, M.J.4
-
4
-
-
84905438552
-
-
Spanish Patent, P201130433, October 3
-
Estella-Hermoso de Mendoza, A., Blanco-Prieto, M.J., Campanero, M.A., Mollinedo, F., Villa-Pulgarín, J., Varela, R., 2011. Development and use of lipidic nanoparticles loaded with edelfosine and ether phospholipids in antitumoral and antiparasitic therapy. Spanish Patent, P201130433, October 3.
-
(2011)
Development and Use of Lipidic Nanoparticles Loaded with Edelfosine and Ether Phospholipids in Antitumoral and Antiparasitic Therapy
-
-
Estella-Hermoso Mendoza, A.1
-
5
-
-
82755182780
-
In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma
-
10.1016/j.jconrel.2011.07.030
-
A. Estella-Hermoso de Mendoza, V. Preat, F. Mollinedo, and M.J. Blanco-Prieto In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma J. Control. Release 156 2011 421 426 10.1016/j.jconrel.2011.07.030
-
(2011)
J. Control. Release
, vol.156
, pp. 421-426
-
-
Estella-Hermoso De Mendoza, A.1
Preat, V.2
Mollinedo, F.3
Blanco-Prieto, M.J.4
-
6
-
-
84861623217
-
Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles
-
10.2217/nnm.11.134
-
A. Estella-Hermoso de Mendoza, M.A. Campanero, H. Lana, J.A. Villa-Pulgarin, J. de la Iglesia-Vicente, F. Mollinedo, and M.J. Blanco-Prieto Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles Nanomedicine 7 2012 679 690 10.2217/nnm.11.134
-
(2012)
Nanomedicine
, vol.7
, pp. 679-690
-
-
Estella-Hermoso De Mendoza, A.1
Campanero, M.A.2
Lana, H.3
Villa-Pulgarin, J.A.4
De La Iglesia-Vicente, J.5
Mollinedo, F.6
Blanco-Prieto, M.J.7
-
7
-
-
0036783411
-
Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells
-
10.2174/1389200023337225
-
C. Gajate, and F. Mollinedo Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells Curr. Drug Metab. 3 2002 491 525 10.2174/1389200023337225
-
(2002)
Curr. Drug Metab.
, vol.3
, pp. 491-525
-
-
Gajate, C.1
Mollinedo, F.2
-
8
-
-
84861220296
-
Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum
-
10.1038/onc.2011.446
-
C. Gajate, M. Matos-da-Silva, H. Dakir el, R.I. Fonteriz, J. Alvarez, and F. Mollinedo Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum Oncogene 31 2011 2627 2639 10.1038/onc.2011.446
-
(2011)
Oncogene
, vol.31
, pp. 2627-2639
-
-
Gajate, C.1
Matos-Da-Silva, M.2
Dakir El, H.3
Fonteriz, R.I.4
Alvarez, J.5
Mollinedo, F.6
-
9
-
-
84901983844
-
Nanoparticles containing insoluble drug for cancer therapy
-
10.1016/j.biotechadv.2013.10.002
-
S. Guo, and L. Huang Nanoparticles containing insoluble drug for cancer therapy Biotechnol. Adv. 13 2013 S0734 S9750 10.1016/j.biotechadv.2013.10.002
-
(2013)
Biotechnol. Adv.
, vol.13
-
-
Guo, S.1
Huang, L.2
-
10
-
-
84866850021
-
Lipid nanoparticles for cancer therapy: State of the art and future prospects
-
10.1517/17425247.2012.717928
-
B. Lasa-Saracibar, A. Estella-Hermoso de Mendoza, M. Guada, C. Dios-Vieitez, and M.J. Blanco-Prieto Lipid nanoparticles for cancer therapy: state of the art and future prospects Expert Opin. Drug Deliv. 9 2012 1245 1261 10.1517/17425247.2012.717928
-
(2012)
Expert Opin. Drug Deliv.
, vol.9
, pp. 1245-1261
-
-
Lasa-Saracibar, B.1
Estella-Hermoso De Mendoza, A.2
Guada, M.3
Dios-Vieitez, C.4
Blanco-Prieto, M.J.5
-
11
-
-
84903721128
-
In vitro intestinal co-culture cell model to evaluate intestinal absorption of edelfosine lipid nanoparticles
-
10.2174/1568026614666140329225340
-
B. Lasa-Saracíbar, M. Guada, V. Sebastián, and M.J. Blanco-Prieto In vitro intestinal co-culture cell model to evaluate intestinal absorption of edelfosine lipid nanoparticles Curr. Top. Med. Chem. 9 2014 1124 1132 10.2174/1568026614666140329225340
-
(2014)
Curr. Top. Med. Chem.
, vol.9
, pp. 1124-1132
-
-
Lasa-Saracíbar, B.1
Guada, M.2
Sebastián, V.3
Blanco-Prieto, M.J.4
-
12
-
-
65649108410
-
Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis
-
10.1124/jpet.108.148254
-
F. Mollinedo, C. Gajate, A.I. Morales, E. del Canto-Janez, N. Justies, F. Collia, J.V. Rivas, M. Modolell, and A. Iglesias Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis J. Pharmacol. Exp. Ther. 329 2009 439 449 10.1124/jpet.108.148254
-
(2009)
J. Pharmacol. Exp. Ther.
, vol.329
, pp. 439-449
-
-
Mollinedo, F.1
Gajate, C.2
Morales, A.I.3
Del Canto-Janez, E.4
Justies, N.5
Collia, F.6
Rivas, J.V.7
Modolell, M.8
Iglesias, A.9
-
13
-
-
84878308394
-
Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma
-
10.1038/bcj.2013.15
-
M. Reis-Sobreiro, G. Roue, A. Moros, C. Gajate, J. de la Iglesia-Vicente, D. Colomer, and F. Mollinedo Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma Blood Cancer J. 3 2013 e118 10.1038/bcj.2013.15
-
(2013)
Blood Cancer J.
, vol.3
, pp. 118
-
-
Reis-Sobreiro, M.1
Roue, G.2
Moros, A.3
Gajate, C.4
De La Iglesia-Vicente, J.5
Colomer, D.6
Mollinedo, F.7
-
14
-
-
84890416308
-
Solid lipid nanoparticles induced hematological changes and inflammatory response in mice
-
10.3109/17435390.2013.782076
-
A.H. Silva, C. Locatelli, F.B. Filippin-Monteiro, B.G. Zanetti-Ramos, A. Conte, and T.B. Creczynski-Pasa Solid lipid nanoparticles induced hematological changes and inflammatory response in mice Nanotoxicology 8 2013 212 219 10.3109/17435390.2013.782076
-
(2013)
Nanotoxicology
, vol.8
, pp. 212-219
-
-
Silva, A.H.1
Locatelli, C.2
Filippin-Monteiro, F.B.3
Zanetti-Ramos, B.G.4
Conte, A.5
Creczynski-Pasa, T.B.6
-
15
-
-
84873163534
-
Anticancer mechanisms and clinical application of alkylphospholipids
-
10.1016/j.bbalip.2012.10.008
-
W.J. van Blitterswijk, and M. Verheij Anticancer mechanisms and clinical application of alkylphospholipids Biochim. Biophys. Acta 1831 2013 663 674 10.1016/j.bbalip.2012.10.008
-
(2013)
Biochim. Biophys. Acta
, vol.1831
, pp. 663-674
-
-
Van Blitterswijk, W.J.1
Verheij, M.2
-
16
-
-
81255209595
-
Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles
-
10.1186/1743-8977-8-33
-
S. Xie, F. Wang, Y. Wang, L. Zhu, Z. Dong, X. Wang, X. Li, and W. Zhou Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles Part. Fibre Toxicol. 8 2011 10.1186/1743-8977-8-33
-
(2011)
Part. Fibre Toxicol.
, vol.8
-
-
Xie, S.1
Wang, F.2
Wang, Y.3
Zhu, L.4
Dong, Z.5
Wang, X.6
Li, X.7
Zhou, W.8
-
17
-
-
84865236833
-
Anti-inflammatory effects and hepatotoxicity of tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats
-
10.1016/j.phymed.2012.06.006
-
M. Xue, Z.-z. Jiang, T. Wu, J. Li, L. Zhang, Y. Zhao, X.-j. Li, L.-Y. Zhang, and S.-y. Yang Anti-inflammatory effects and hepatotoxicity of tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats Phytomedicine 19 2012 998 1006 10.1016/j.phymed.2012.06.006
-
(2012)
Phytomedicine
, vol.19
, pp. 998-1006
-
-
Xue, M.1
Jiang, Z.-Z.2
Wu, T.3
Li, J.4
Zhang, L.5
Zhao, Y.6
Li, X.-J.7
Zhang, L.-Y.8
Yang, S.-Y.9
-
18
-
-
84866487784
-
Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats
-
10.1016/j.ejps.2012.05.012
-
M. Xue, Y. Zhao, X.-j. Li, Z.-z. Jiang, L. Zhang, S.-h. Liu, X.-m. Li, L.-Y. Zhang, and S.-y. Yang Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats Eur. J. Pharm. Sci. 47 2012 713 717 10.1016/j.ejps.2012.05.012
-
(2012)
Eur. J. Pharm. Sci.
, vol.47
, pp. 713-717
-
-
Xue, M.1
Zhao, Y.2
Li, X.-J.3
Jiang, Z.-Z.4
Zhang, L.5
Liu, S.-H.6
Li, X.-M.7
Zhang, L.-Y.8
Yang, S.-Y.9
|